In PD-L1/LAG-3 double knock-in mice bearing human PD-L1 knock-in MC3 tumors, IBI323 exhibited stronger antitumor activity than each parental antibody, and these antitumor responses were associated with an increase in the number of tumor-specific CD8+ and CD4+ T cells [189]. The gene discussed is CD4; the disease is neoplasm.